Company webinar

BCAL Diagnostics (ASX:BDX)

Watch our webinar with BCAL Diagnostics, featuring Executive Chair Jayne Shaw. An interview followed by live Q&A with the audience.

Date
August 27, 2024
Time
Where
Online
Entry
Free
Jayne Shaw
Jayne Shaw
Executive Chair, BCAL Diagnostics (ASX:BDX)

About the company

BCAL Diagnostics Limited specialises in the development and commercialisation of innovative diagnostic technologies focused on early detection and improved patient outcomes. Our primary product is a blood-based diagnostic test for breast cancer that aims to provide a non-invasive, accurate, and early detection method. Our long-term vision is to revolutionise the field of diagnostics by providing accessible, reliable, and non-invasive testing solutions that enhance early detection and improve patient outcomes globally. Our first product will be introduced as another diagnostic tool for the early detection of breast cancer, which will improve women's diagnostic and survivability rates. This vision is crucial as it aligns with our commitment to advancing healthcare and saving lives through early intervention and effective treatment.

Key topics

  • BCAL Diagnostics’ technology
  • Milestones investors can expect in the next 6 to 12 months
  • How BCAL plans to scale its operations
  • Key growth drivers

Watch the recording

More webinars

All webinars →

Go beyond the presentation

Management tells one side of the story. Sharewise clients get independent research and Advisor access across ASX, US and global markets.

Explore our services →